Companies /Healthcare

Fate Therapeutics Inc

NASDAQ: FATE Biotechnology
$1.28
▼ $0.06 (−4.48%) today
Markets closed · 6:34am ET

FATE Coverage Page 2

11:50am ET
Health and Healthcare

Why Fate Therapeutics Is One of ASH’s Biggest Winners

Fate Therapeutics shares jumped on Monday after the firm announced new preclinical data for its off-the-shelf, multi-antigen targeting natural killer cell product candidate derived from a clonal master engineered induced pluripotent stem…

Chris Lange